Trademark: 88624711
Status Date
Monday, April 24, 2023
Filing Date
Friday, September 20, 2019
Published for Opposition
Tuesday, January 28, 2020
Abandoned Date
Monday, April 24, 2023
5 Pharmaceutical preparations for the treatment of blood or bleeding disorders; blood products for the treatment of hereditary angioedema; blood proteins for therapeutic use
Apr 24, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 24, 2023
Abandonment - No Use Statement Filed
Sep 8, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 7, 2022
Sou Extension 5 Granted
Aug 24, 2022
Sou Extension 5 Filed
Sep 7, 2022
Case Assigned To Intent To Use Paralegal
Aug 24, 2022
Teas Extension Received
Feb 26, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 24, 2022
Sou Extension 4 Granted
Feb 24, 2022
Sou Extension 4 Filed
Feb 24, 2022
Teas Extension Received
Aug 26, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 24, 2021
Sou Extension 3 Granted
Aug 24, 2021
Sou Extension 3 Filed
Aug 24, 2021
Teas Extension Received
Feb 26, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 24, 2021
Sou Extension 2 Granted
Feb 24, 2021
Sou Extension 2 Filed
Feb 24, 2021
Teas Extension Received
Aug 22, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 20, 2020
Sou Extension 1 Granted
Aug 20, 2020
Sou Extension 1 Filed
Aug 20, 2020
Teas Extension Received
Mar 24, 2020
Noa E-Mailed - Sou Required From Applicant
Jan 28, 2020
Official Gazette Publication Confirmation E-Mailed
Jan 28, 2020
Published For Opposition
Jan 8, 2020
Notification Of Notice Of Publication E-Mailed
Dec 23, 2019
Approved For Pub - Principal Register
Dec 20, 2019
Assigned To Examiner
Sep 26, 2019
New Application Office Supplied Data Entered
Sep 24, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
